Oncology
The findings of a recent study published in Science Advances suggest that a high-salt diet modulates the gut microbiota in ways that boost tumor immunity.
Chemotherapy treatment and intestinal diseases can alter the process of programmed cell death, which can lead to gastrointestinal tract's infections.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
Probiotics such as Lactobacillus and Bifidobacterium can activate a person’s immune system and improve the response to some anti-cancer therapies.
TCGA allows to explore the role of tissue-resident microbiota in various cancer types and identifying predictive microbial biomarkers.
Decreased microbial diversity and increased abundance of Firmicutes phylum in the respiratory tract may be associated with an increased risk of lung cancer.
Researches suggest that Lachnospiraceae and Enterococcaceae, as well as bacterial metabolites such as propionate can contribute to radioprotection.
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
